vanderbilt-Ingram Cancer Center
Nashville, Tennessee 37235
48 studies enrolling now · 620 studies all time
What they study most
AL Amyloidosis, AML, AML/MDS, Acute Disease, Acute Leukemia in Remission, Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation, Acute Myeloid Leukemia With Multilineage Dysplasia
Studies at this site
- A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors — Recruiting now
- A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma — Recruiting now
- A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC) — Recruiting now
- DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy — Recruiting now
- SMP-3124LP in Adults With Advanced Solid Tumors — Recruiting now
- A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) — Recruiting now
- Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In — Recruiting now
- FOG-001 in Locally Advanced or Metastatic Solid Tumors — Recruiting now
- Study of DCC-2812 in Participants With Advanced Genitourinary Cancers — Recruiting now
- Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor — Recruiting now
- Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy — Recruiting now
- Study of CHS-114 in Participants With Advanced Solid Tumors — Recruiting now
- A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer — Recruiting now
- SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance) — Recruiting now
- A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials — Recruiting now
- DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM) — Recruiting now
- A Study of PHST001 in Advanced Solid Tumors — Recruiting now
- A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors — Recruiting now
- The Lilac Device Trial - IMPACT: A Clinical Investigation on IMproving Peripheral Neuropathy Induced by Chemotherapy With Advanced Compression Technology - A Safety and Efficacy Study — Recruiting now
- A Phase 1/1b Study of IAM1363 in HER2 Cancers — Recruiting now
- Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors — Recruiting now
- Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis — Recruiting now
- Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy — Recruiting now
- A Study to Evaluate the Safety, Tolerability of INCB160058 in Participants With Myeloproliferative Neoplasms — Recruiting now
- Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA) — Recruiting now
- Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer — Recruiting now
- Evaluation of RBS2418 in Combination With Tremelimumab Plus Durvalumab in Participants With Advanced Unresectable Hepatocellular Carcinoma — Recruiting now
- A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer — Recruiting now
- Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma — Recruiting now
- Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO) — Recruiting now
- A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors — Recruiting now
- Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients — Recruiting now
- Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors — Recruiting now
- A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies — Recruiting now
- TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers — Recruiting now
- Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma — Recruiting now
- cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease — Recruiting now
- Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors — Recruiting now
- A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD) — Recruiting now
- Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion — Recruiting now
- Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants — Recruiting now
- Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer — Recruiting now
- Studying Health Outcomes After Treatment in Patients With Retinoblastoma — Recruiting now
- Inherited CAncer REgistry — Recruiting now
- Collecting and Storing Tissue Samples From Women With or Without Breast Cancer — Recruiting now
- Genetics of Appendix Cancer Study — Recruiting now
- Preserving Fertility After Colorectal Cancer Study — Recruiting now
- Hypofractionated Radiotherapy Followed by Surgical Resection in the Treatment of Soft Tissue Sarcomas — Recruiting now
- Low-Dose Total Skin Electron Therapy in Treating Patients With Refractory or Relapsed Stage IB-IIIA Mycosis Fungoides — Recruiting now
- Gabapentin & Ketamine for Prevention/Treatment of Acute/Chronic Pain in Locally Advanced Head and Neck Cancer — Recruiting now